The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MDNA | -51.59% | -81.73% | -28.81% | -49% |
| S&P | +16.23% | +94.45% | +14.22% | +169% |
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.01M | -275.7% |
| Market Cap | $43.28M | -61.4% |
| Market Cap / Employee | $2.40M | 0.0% |
| Employees | 18 | 12.5% |
| Net Income | -$3.56M | -34.0% |
| EBITDA | -$3.97M | -34.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $14.99M | -42.4% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.08M | 0.0% |
| Short Term Debt | $0.04M | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -42.71% | 32.4% |
| Return On Invested Capital | -148.34% | -7.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.56M | -48.6% |
| Operating Free Cash Flow | -$2.56M | -50.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 6.40 | 5.94 | 4.38 | 3.71 | -86.08% |
| Price to Tangible Book Value | 6.41 | 5.96 | 4.40 | 3.72 | -86.20% |
| Enterprise Value to EBITDA | -20.32 | -18.86 | -7.70 | -9.21 | -67.14% |
| Return on Equity | -122.3% | -150.3% | -100.5% | -69.2% | -33.91% |
| Total Debt | $0.13M | $0.12M | $0.12M | $0.12M | - |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
